Find Corporate Waste

Tag: False Claims Act

  • Texas Physician to Pay $3.5M for Fraudulent COVID Billing Scheme Targeting Uninsured Program

    The U.S. Attorney’s Office for the Eastern District of Texas announced that Dr. Samad Khan has agreed to pay $3.5 million to resolve allegations of fraudulent billing to the federal government—thanks to a federal investigation targeting misuse of emergency pandemic funds.

    Dr. Samad Khan, owner of SK Primary Care, PLLC, was accused of submitting false claims to the COVID-19 Uninsured Program, which reimbursed providers for testing and treatment of uninsured individuals during the public health emergency. From April 2020 to October 2021, Khan allegedly billed for evaluation and management (E/M) services that were never performed.

    Under the Current Procedural Terminology (CPT) coding system, higher-level E/M services (CPT 99202–99205, 99212–99215) are intended to reflect complex medical care requiring direct attention by a physician or qualified healthcare provider.

    Patients at Khan’s walk-up and drive-through COVID test sites were allegedly not evaluated by any licensed providers—only medical assistants conducted nasal swabs, a service properly billed under CPT 99211.

    Khan allegedly submitted approximately 400,000 claims under higher-level codes and was the sole rendering provider listed. Many of the claims were for duplicated visits, with one charge for the test and another for delivering results—often via automated message, not through medical consultation.

    “These were not medical appointments,” said Acting U.S. Attorney Jay R. Combs. “Patients received a nasal swab and later got a text message with their results. Yet the government was billed for comprehensive office visits.”

    According to the complaint, Khan, in coordination with SK Primary Care’s management company, used inflated codes to maximize reimbursement from the Uninsured Program. The scheme generated millions in overpayments—diverting public funds meant to support pandemic response for those without health insurance.

    Find Corporate Waste is tracking a growing number of fraud cases involving COVID-19 relief funds—an urgent reminder that emergency spending, no matter how critical, requires oversight. Whistleblowers and investigators remain essential to protecting the integrity of public programs.

  • Lockheed Martin Pays $70 Million to Settle False Claims Allegations Over Defective Pricing in Missile Contracts

    In a significant enforcement action announced by the U.S. Department of Justice, Lockheed Martin Corporation has agreed to pay $70 million to resolve allegations that it violated the False Claims Act (FCA) by submitting defectively priced contracts for missile sales to the Department of Defense.

    Click For Details

    The case centers on the Terminal High Altitude Area Defense (THAAD) system, a key component of U.S. missile defense architecture. DOJ officials alleged that Lockheed Martin’s subcontractor, L3Harris Technologies, intentionally provided inaccurate cost data during negotiations, which Lockheed Martin then passed on to the government without adequate disclosure or correction. As a result, the U.S. Army Missile Command allegedly awarded contracts based on inflated cost and pricing data, causing the government to overpay for missile components.

    This case was brought to light by a private whistleblower, known legally as a relator, who filed a lawsuit under the qui tam provisions of the False Claims Act. These provisions empower private citizens to sue on behalf of the federal government when they possess non-public evidence of fraud involving taxpayer dollars.

    In return, whistleblowers may be eligible to receive a portion of the recovery. In this case, the relator will receive $13.7 million from the settlement—a recognition of the role that private citizens can play in holding large corporations accountable.

    At Find Corporate Waste, we believe that the integrity of public spending starts with accountability. This case against Lockheed Martin highlights how whistleblowers can protect taxpayer dollars and expose fraudulent schemes that would otherwise go unchecked. We are committed to supporting those who step forward, guiding them through the complex landscape of False Claims Act litigation, and ensuring their efforts lead to meaningful recovery for the American people. If you have information about fraud, waste, or abuse of government funds, Find Corporate Waste is here to help you take the first step.

  • Whistleblower Action Exposes Corporate Waste and Tariff Evasion in $8.1 Million FCA Settlement

    In a recent settlement announced by the U.S. Department of Justice, a California-based flooring company agreed to pay $8.1 million to resolve allegations of customs fraud—thanks to the actions of a whistleblower acting under the False Claims Act’s qui tam provision.

    Evolutions Flooring Inc., along with its owners Richard and Brian Abcarian, was accused of evading U.S. import duties by falsely labeling Chinese-manufactured flooring products as originating from Malaysia. Between 2011 and 2019, the company allegedly used this scheme to circumvent anti-dumping and countervailing duties imposed on multilayered wood flooring from China.

    Under federal trade laws, importers must truthfully declare the country of origin for all goods entering the United States. The government alleged that Evolutions Flooring submitted false documentation to U.S. Customs and Border Protection, routing shipments through Malaysia to avoid tariffs—triggering False Claims Act liability.

    This case was brought to light not by routine customs enforcement—but by a private individual known legally as a relator. Under the qui tam provision of the False Claims Act, private citizens with knowledge of fraud against the federal government may file lawsuits on its behalf. If the case leads to a financial recovery, the whistleblower may receive a share of the settlement.

    The False Claims Act remains a vital tool for preventing fraud — not only in healthcare and government contracting, but increasingly in the international trade sector. As global supply chains expand and duty circumvention schemes grow more complex, whistleblowers will remain an essential source of investigative leads for enforcement.

  • Whistleblower Action Uncovers Medicare Billing Fraud in Lehigh Valley

    In a recent settlement announced by the U.S. Attorney’s Office for the Eastern District of Pennsylvania, a Lehigh Valley-based doctor agreed to pay $45,000 to resolve allegations of healthcare fraud—thanks to the actions of a whistleblower acting under the False Claims Act’s qui tam provision.

    Dr. Stephen Renn of Bethlehem was accused of submitting claims to Medicare and Medicaid for psychotherapy services without the required supporting documentation between 2016 and 2020. Under federal rules, physicians must maintain detailed records to justify billing levels. The government alleged that Dr. Renn failed to do so, triggering False Claims Act liability.

    This case was brought to light not by internal audits or regulators—but by a private individual known legally as a relator.

    Under the qui tam provision of the False Claims Act, private citizens with evidence of fraud against federal programs can file lawsuits on behalf of the U.S. government. If the case results in a financial recovery, the whistleblower may receive a portion of the settlement.

    Although the relator remains anonymous, their role was essential. Without their initiative, this case—and the associated improper billing practices—may never have been uncovered.

    The settlement, while not an admission of guilt, underscores the growing importance of whistleblowers in protecting taxpayer dollars and ensuring healthcare compliance. It also serves as a warning to other providers: inadequate documentation can lead to legal and financial consequences.

    This case is another example of how the False Claims Act continues to serve as a powerful tool for fraud prevention, especially in the healthcare sector. With billions of dollars flowing through programs like Medicare and Medicaid, the government relies heavily on individuals to report wrongdoing.

    As healthcare spending continues to rise, so does the potential for abuse. But as this case proves, one person—armed with information and the courage to act—can help ensure accountability and recover public funds.

    FCW remains committed to exposing similar patterns of fraud nationwide—ensuring that every taxpayer dollar is accounted for and every violation brought to light.